LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...

Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...

The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...

As a pioneer of harnessing artificial intelligence (AI) to drug discovery, Insilico Medicine Inc. recently made breakaway progress to bring a generative... Blood cancer drug venetoclax could ...

Cochlear Limited, the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology ...

As technology evolves, companies are taking steps to make their tech as inclusive as possible. From motorized lipstick applicators to innovative bone conduction headphones, it's clear that for many ...